| scholarly article | Q13442814 |
| P2093 | author name string | Mizuuchi K | |
| Bushman FD | |||
| Craigie R | |||
| Engelman A | |||
| P2860 | cites work | The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro | Q45851069 |
| The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. | Q54707474 | ||
| Stoichiometric use of the transposase of bacteriophage Mu | Q70183891 | ||
| Molecular targets for AIDS therapy | Q28323494 | ||
| Retroviral DNA integration directed by HIV integration protein in vitro | Q28646770 | ||
| Integration of human immunodeficiency virus type 1 DNA in vitro | Q33608319 | ||
| Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity | Q33666234 | ||
| Genetic recombination of human immunodeficiency virus | Q36782092 | ||
| Removal of 3'-OH-terminal nucleotides from blunt-ended long terminal repeat termini by the avian retrovirus integration protein | Q36793581 | ||
| Human immunodeficiency virus integration in a cell-free system | Q36807041 | ||
| The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration | Q36832318 | ||
| Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA | Q37402258 | ||
| Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes | Q37402708 | ||
| Unraveling retrovirus integration | Q38137897 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2729-2734 | |
| P577 | publication date | 1991-05-01 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | A rapid in vitro assay for HIV DNA integration | |
| P478 | volume | 19 |
| Q40969466 | A high-throughput assay for Tn5 Tnp-induced DNA cleavage |
| Q40400122 | A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein |
| Q38359623 | A molecular mechanics and dynamics study of alternate triple-helices involving the integrase-binding site of the HIV-1 virus and oligonucleotides having a 3'-3' internucleotide junction |
| Q33502482 | A nonradioactive plate-based assay for stimulators of nonspecific DNA nicking by HIV-1 integrase and other nucleases |
| Q73789114 | A rapid and quantitative assay for inhibition of 3' cleavage activity of HIV-1 integrase |
| Q38916846 | A review on architecture of the gag-pol ribosomal frameshifting RNA in human immunodeficiency virus: a variability survey of virus genotypes |
| Q38358758 | Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro |
| Q36666299 | Architecture and assembly of HIV integrase multimers in the absence of DNA substrates |
| Q33838063 | Biochemical and pharmacological analyses of HIV-1 integrase flexible loop mutants resistant to raltegravir |
| Q38318959 | Branched oligonucleotide-intercalator conjugate forming a parallel stranded structure inhibits HIV-1 integrase |
| Q37281481 | Comparison of metal-dependent catalysis by HIV-1 and ASV integrase proteins using a new and rapid, moderate throughput assay for joining activity in solution |
| Q37139736 | Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants |
| Q46652865 | Development and application of a high-throughput screening assay for HIV-1 integrase enzyme activities. |
| Q36672092 | Discovery and in vitro development of AIDS antiviral drugs as biopharmaceuticals |
| Q35077531 | Expression and partial purification of enzymatically active recombinant Ty1 integrase in Saccharomyces cerevisiae |
| Q40522224 | Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA. |
| Q30407372 | HIV virions as nanoscopic test tubes for probing oligomerization of the integrase enzyme. |
| Q38348637 | HIV-1 integrase and virus and cell DNAs: complex formation and perturbation by inhibitors of integration |
| Q34050694 | HIV-1 integrase inhibitors: past, present, and future |
| Q37034614 | HIV-1 integrase inhibitors: update and perspectives |
| Q38295884 | HIV-1 preintegration complexes preferentially integrate into longer target DNA molecules in solution as detected by a sensitive, polymerase chain reaction-based integration assay |
| Q33221506 | Homogeneous high-throughput screening assays for HIV-1 integrase 3beta-processing and strand transfer activities |
| Q40065873 | Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions |
| Q28379456 | Identification of a nucleotide binding site in HIV-1 integrase |
| Q34764444 | Incorporation of a fluorescent guanosine analog into oligonucleotides and its application to a real time assay for the HIV-1 integrase 3'-processing reaction |
| Q39352071 | Inhibiting the HIV integration process: past, present, and the future. |
| Q40391827 | Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds |
| Q44665762 | Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides |
| Q28369221 | Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate |
| Q33929260 | Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31 |
| Q28378683 | Inhibitors of human immunodeficiency virus integrase |
| Q33671224 | Inhibitors of human immunodeficiency virus integrase. |
| Q34397376 | Integrase inhibitors to treat HIV/AIDS. |
| Q39783580 | Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins |
| Q40295190 | Measurement of In Vitro Integration Activity of HIV-1 Preintegration Complexes. |
| Q41963850 | Mechanistic and pharmacological analyses of HIV-1 integration |
| Q34437364 | Metal binding by the D,DX35E motif of human immunodeficiency virus type 1 integrase: selective rescue of Cys substitutions by Mn2+ in vitro |
| Q46545766 | Monitoring the HIV-1 integrase enzymatic activity using atomic force microscopy in a 2LTR system |
| Q92992903 | Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition |
| Q27678745 | New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action |
| Q37325980 | Oligonucleotide-based assays for integrase activity |
| Q33398037 | Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration |
| Q24316120 | Peptides that bind the HIV-1 integrase and modulate its enzymatic activity--kinetic studies and mode of action |
| Q40486948 | Present Status and Future Prospects for HIV Therapies |
| Q36587864 | Proteomic analysis of early HIV-1 nucleoprotein complexes |
| Q30635816 | Rapid microtiter assays for poxvirus topoisomerase, mammalian type IB topoisomerase and HIV-1 integrase: application to inhibitor isolation |
| Q36717795 | Rapid solution assays for retroviral integration reactions and their use in kinetic analyses of wild-type and mutant Rous sarcoma virus integrases |
| Q35952270 | Repair of transposable phage Mu DNA insertions begins only when the E. coli replisome collides with the transpososome |
| Q34059896 | Resistance to integrase inhibitors |
| Q34643561 | Retroviral integrase proteins and HIV-1 DNA integration |
| Q36723801 | Role of integrase inhibitors in the treatment of HIV disease |
| Q38349833 | Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix |
| Q38307527 | Substrate features important for recognition and catalysis by human immunodeficiency virus type 1 integrase identified by using novel DNA substrates |
| Q35050390 | Targeting HIV-1 integrase |
| Q36581635 | The Mu story: how a maverick phage moved the field forward |
| Q40393204 | Therapy Other Than Reverse Transcriptase Inhibitors for HIV Infection |
| Q28369657 | Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells |
| Q40762611 | Viral gene products and replication of the human immunodeficiency type 1 virus |
Search more.